Allakos Inc.

ALLAKOS

Pharmaceutical and therapeutic preparations for the treatment of gastrointestinal, skin, multi-organ, respiratory, ophthalmic, autoimmune, cardiovascular, central nervous system, endocrine, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, psychiatric, urogenital, urological, and viral diseases and disorders; pharmaceutical and therapeutic preparations for the treatment of eosinophilic gastritis, eosinophilic gastroenteritis, eosinophilic duodenitis, eosinophilic esophagitis, ulcerative colitis, crohn's disease, irritable bowel syndrome, functional gastrointestinal disease, chronic urticaria, atopic dermatitis, indolent systemic mastocytosis, mast cell activation syndrome, idiopathic pulmonary fibrosis, eosinophilic asthma, asthma, conjunctivitis, vitiligo, and viral infections;

ALLAKOS

Scientific, medical, pharmaceutical, therapeutic, and biochemical research and development, and consultation related thereto;

LINSIGRA

Pharmaceutical and therapeutic preparations for the treatment of gastrointestinal, skin, multi-organ, respiratory, ophthalmic, autoimmune, cardiovascular, central nervous system, endocrine, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, psychiatric, urogenital, urological, and viral diseases and disorders; pharmaceutical and therapeutic preparations for the treatment of eosinophilic gastritis, eosinophilic gastroenteritis, eosinophilic duodenitis, eosinophilic esophagitis, ulcerative colitis, crohn's disease, irritable bowel syndrome, functional gastrointestinal disease, chronic urticaria, atopic dermatitis, indolent systemic mastocytosis, mast cell activation syndrome, idiopathic pulmonary fibrosis, eosinophilic asthma, asthma, conjunctivitis, vitiligo, and viral infections;

LIRENITY

Pharmaceutical and therapeutic preparations for the treatment of gastrointestinal, skin, multi-organ, respiratory, ophthalmic, autoimmune, cardiovascular, central nervous system, endocrine, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, psychiatric, urogenital, urological, and viral diseases and disorders; pharmaceutical and therapeutic preparations for the treatment of eosinophilic gastritis, eosinophilic gastroenteritis, eosinophilic duodenitis, eosinophilic esophagitis, ulcerative colitis, crohn's disease, irritable bowel syndrome, functional gastrointestinal disease, chronic urticaria, atopic dermatitis, indolent systemic mastocytosis, mast cell activation syndrome, idiopathic pulmonary fibrosis, eosinophilic asthma, asthma, conjunctivitis, vitiligo, and viral infections;

LIREOS

Pharmaceutical and therapeutic preparations for the treatment of gastrointestinal, skin, multi-organ, respiratory, ophthalmic, autoimmune, cardiovascular, central nervous system, endocrine, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, psychiatric, urogenital, urological, and viral diseases and disorders; pharmaceutical and therapeutic preparations for the treatment of eosinophilic gastritis, eosinophilic gastroenteritis, eosinophilic duodenitis, eosinophilic esophagitis, ulcerative colitis, crohn's disease, irritable bowel syndrome, functional gastrointestinal disease, chronic urticaria, atopic dermatitis, indolent systemic mastocytosis, mast cell activation syndrome, idiopathic pulmonary fibrosis, eosinophilic asthma, asthma, conjunctivitis, vitiligo, and viral infections;

SIGLECTIVE

Pharmaceutical and therapeutic preparations for the treatment of gastrointestinal, skin, multi-organ, respiratory, ophthalmic, autoimmune, cardiovascular, central nervous system, endocrine, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, psychiatric, urogenital, urological, and viral diseases and disorders; pharmaceutical and therapeutic preparations for the treatment of eosinophilic gastritis, eosinophilic gastroenteritis, eosinophilic duodenitis, eosinophilic esophagitis, ulcerative colitis, crohn's disease, irritable bowel syndrome, functional gastrointestinal disease, chronic urticaria, atopic dermatitis, indolent systemic mastocytosis, mast cell activation syndrome, idiopathic pulmonary fibrosis, eosinophilic asthma, asthma, conjunctivitis, vitiligo, and viral infections;